ELISA instead of indirect IF in patients with BP

Archives of Dermatology

Volumn 147, Issue 3, 2011, Pages 291-292

  Chan, Lawrence S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COLLAGEN TYPE 17; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ANTIBODY DETECTION; BLISTER; BULLOUS PEMPHIGOID; CLINICAL PRACTICE; CONSENSUS DEVELOPMENT; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; INTERMETHOD COMPARISON; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; SKIN EXAMINATION; URTICARIA;

AUTOANTIGENS; CARRIER PROTEINS; CYTOSKELETAL PROTEINS; DERMATOLOGY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; NERVE TISSUE PROTEINS; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BULLOUS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 79952830592     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.24     Document Type: Short Survey

References (2)

1. Giudice GJ, Wilske KC, Anhalt GJ, et al. Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis. J Invest Dermatol. 1994;102(6):878-881. (Pubitemid 24210382)
2. Zillikens D, Mascaro JM, Rose PA, et al. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol. 1997;109(5):679-683. (Pubitemid 27465925)